The Landscape of Kinase Domain Duplication (KDD) in Chinese Lung Cancer Patients

被引：0
|
作者：
Wang, P. [1 ]
Wu, D. [2 ]
Xie, Y. [3 ]
Shi, X. [4 ]
Hou, T. [5 ]
Chen, S. [5 ]
Xiang, J. [5 ]
Shao, L. [5 ]
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Resp Med, Hangzhou, Peoples R China
[2] Shenzhen Peoples Hosp, Dept Resp Med, Shenzhen, Peoples R China
[3] Peking Univ, Shenzhen Hosp, Dept Thorac Surg, Shenzhen, Peoples R China
[4] Fujian Med Univ, Affiliated Hosp 1, Dept Med Oncol, Fuzhou, Peoples R China
[5] Burning Rock Biotech, Guangzhou, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
kinase domain duplication; lung cancer; Chinese;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P89.09
引用
收藏
页码：S691 / S692
页数：2
相关论文
共 50 条
  • [1] The landscape of kinase domain duplication in Chinese lung cancer patients
    Wu, Di
    Xie, Yuancai
    Jin, Chang'e
    Qiu, Jinfan
    Hou, Ting
    Du, Haiwei
    Chen, Songan
    Xiang, Jianxing
    Shi, Xi
    Liu, Junling
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (24)
  • [2] Lung Adenocarcinoma Patient with EGFR Kinase Domain Duplication (KDD) and Its Response to Icotinib: A Case Report
    Wang, W.
    Xu, C.
    Tan, Q.
    Song, Z.
    Zhuang, W.
    Chen, Y.
    Xiong, L.
    Chen, G.
    Fang, M.
    Lv, T.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2261 - S2261
  • [3] The Landscape of FGFR Alteration in Chinese Patients with Lung Cancer
    Wang, H.
    Ning, R.
    Zheng, H.
    Pan, Q.
    Yu, J.
    Zhang, J.
    Zhao, D.
    Wang, W.
    Zhang, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S570 - S571
  • [4] Clinical and Genomic Features of EGFR-KDD/EGFR Rearrangements of Chinese Lung Cancer Patients
    Zhou, C.
    Zhao, J.
    Gu, D.
    Chen, R.
    Xia, X.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S688 - S688
  • [5] Colorectal cancer harboring EGFR kinase domain duplication response to EGFR tyrosine kinase inhibitors
    Kondo, Tomohiro
    Kikuchi, Osamu
    Yamamoto, Yoshihiro
    Sunami, Tomohiko
    Wang, Yafeng
    Fukuyama, Keita
    Saito, Tomoki
    Nakahara, Hideto
    Minamiguchi, Sachiko
    Kanai, Masashi
    Sueyoshi, Atsushi
    Muto, Manabu
    ONCOLOGIST, 2024,
  • [6] Durable response to EGFR tyrosine kinase inhibitors in a patient with non-small cell lung cancer harboring an EGFR kinase domain duplication
    Hirokawa, Esuteru
    Watanabe, Satomi
    Sakai, Kazuko
    Takeda, Masayuki
    Sato, Chihiro
    Takahama, Takayuki
    Nishio, Kazuto
    Nakagawa, Kazuhiko
    THORACIC CANCER, 2021, 12 (16) : 2283 - 2287
  • [7] The Landscape of NFE2L2 Alteration in Chinese Lung Cancer Patients
    Dou, X.
    Wang, Z.
    Lu, W.
    Miao, L.
    Ma, R.
    Ren, D.
    Wang, C.
    Liu, C.
    Li, L.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S589 - S589
  • [8] EGFR polymorphism of the kinase domain in Japanese lung cancer
    Sasaki, Hidefumi
    Endo, Katsuhiko
    Takada, Minoru
    Kawahara, Masaaki
    Tanaka, Hisaichi
    Kitahara, Naoto
    Matsumura, Akihide
    Iuchi, Keiji
    Kawaguchi, Tomoya
    Okuda, Katsuhiro
    Kawano, Osamu
    Yukiue, Harubiro
    Yokoyama, Tomoki
    Yano, Motoki
    Fujii, Yoshitaka
    JOURNAL OF SURGICAL RESEARCH, 2008, 148 (02) : 260 - 263
  • [9] Next Generation Sequencing Reveals the Genetic Landscape of JAK Family in Chinese Lung Cancer Patients
    Wang, C.
    He, Q.
    Wang, D.
    Wang, X.
    Zhang, X.
    Ma, T.
    Xia, L.
    Gui, L.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S432 - S432
  • [10] Identification of EGFR kinase domain mutations among lung cancer patients in China: implication for targeted cancer therapy
    Qin, BM
    Chen, X
    Zhu, JD
    Pei, DQ
    CELL RESEARCH, 2005, 15 (03) : 212 - 217
12345